CM
SLRN

Caption Management’s ACELYRIN SLRN Stock Holding History

Caption Management’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-451,100
Closed -$3.04M – 1479
2024
Q1 		$3.04M Buy
+451,100
New +$3.43M 0.05% 427
2023
Q4 		– Sell
-25,000
Closed -$254K – 1642
2023
Q3 		$254K Buy
+25,000
New +$531K ﹤0.01% 1065

Other funds holding SLRN

ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Caption Management's SLRN Position: Q4 2023 in Review

Caption Management sold out of ACELYRIN (SLRN) in Q4 2023, closing a stake of 50,377 shares — an estimated $512K sold.

Caption Management first reported a position in SLRN in Q3 2023 and held it in 1 quarter. The position peaked at $512K in Q3 2023. 110 funds tracked by Wall St. Rank hold SLRN as of Q4 2023.

  • Caption Management reported no remaining ACELYRIN position as of Q4 2023 after selling out during the quarter.
  • Caption Management sold 50,377 ACELYRIN shares in Q4 2023, an estimated $512K.
  • Caption Management first reported a position in ACELYRIN in Q3 2023 and held it in 1 quarter.
  • Caption Management's ACELYRIN position peaked at $512K in Q3 2023.
  • 110 funds tracked by Wall St. Rank held ACELYRIN as of Q4 2023.

Based on Caption Management's 13F filing for Q4 2023, filed 14 Feb 2024.